Skip to content

Clinical trials

Terminated Lymphoma, B-Cell, Marginal Zone trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Status: Terminated Country / region: United States Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20032
20047
20058
20065
20074
200810
20095
201011
20111
20123
20138
20144
20153
20164
20173
20183
20194
20202
20214
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated109

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
Masonic Cancer Center, University of Minnesota8
City of Hope Medical Center5
Fred Hutchinson Cancer Center5
OHSU Knight Cancer Institute5
Gilead Sciences4
MEI Pharma, Inc.4
Vanderbilt-Ingram Cancer Center4
Barbara Ann Karmanos Cancer Institute3
Case Comprehensive Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone109
Lymphoma, Follicular103
Leukemia, Lymphocytic, Chronic, B-Cell93
Lymphoma, Mantle-Cell85
Lymphoma, Large B-Cell, Diffuse79
Lymphoma, Non-Hodgkin77
Burkitt Lymphoma63
Precursor Cell Lymphoblastic Leukemia-Lymphoma60
Lymphoma, Large-Cell, Immunoblastic54
Hodgkin Disease49

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.